Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2010
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816134 Method of extensive culture of antigen-specific cytotoxic T cells
10/19/2010US7815921 Using patient's leukocyte concentration after incubation with colony stimulation factor as evaluative tool in predicting susceptibility to infection, bone marrow and autoimmune diseases after chemotherapeutic treatments
10/19/2010US7815920 Method of preparing an antigen-containing formulation
10/19/2010US7815914 methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; provides for reovirus treatment of mammals to treat proliferative disorders including breast tumors, a subset of tumors in which mutation of ras gene is not believed to play significant role
10/19/2010US7815910 Antigen and adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15; for application orally, nasally, rectally, or vaginally
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815904 Administration of an activated form of ultra-low doses of antibodies to an antigen, obtained using homeopathic techniques; drug dependence/drug withdrawal; side effect reduction
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2468314C The use of water-soluble lamarin in the treatment of cancer
10/19/2010CA2458699C Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2433417C Novel 1,2-diphenylethene derivatives for treatment of immune diseases
10/19/2010CA2420159C Model animal for type iii allergy inflammation
10/19/2010CA2415577C Use of cox-2 inhibitors for preventing immunodeficiency
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/19/2010CA2374631C Benzene derivatives, process for their preparation and pharmaceutical compositions containing them
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2309115C Use of cytokines and mitogens to inhibit pathological immune responses
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/14/2010WO2010117829A2 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
10/14/2010WO2010117662A1 Modulators of s1p and methods of making and using
10/14/2010WO2010117071A1 Ubiquitin fusion gene, and dna vaccine using same
10/14/2010WO2010117050A1 Solid preparation containing dibenz[b,e]oxepine derivative
10/14/2010WO2010116669A1 Tumor immunity inducer
10/14/2010WO2010115836A1 Substituted piperidines as ccr3 antagonists
10/14/2010WO2010115786A1 Anti-il-23 immunoglobulins
10/14/2010WO2010115751A2 Oxadiazole derivatives
10/14/2010WO2010115278A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010WO2010115238A1 Method for treating immune disorders
10/14/2010WO2010115230A1 Immunogenic composition and uses thereof
10/14/2010WO2010115229A1 Immunogenic composition and uses thereof
10/14/2010US20100261779 Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity
10/14/2010US20100261766 Phenyl-Oxetanyl-Derivatives
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261746 Pharmaceutical formulation
10/14/2010US20100261745 Pharmaceutical formulation
10/14/2010US20100261744 Pharmaceutical formulation
10/14/2010US20100261725 Compounds that modulate intracellular calcium
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261702 Thiophene derivatives as agonists of s1p1/edg1
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100261687 Substituted piperidines as ccr3 antagonists
10/14/2010US20100261671 Inulin products with improved nutritional properties
10/14/2010US20100261660 Novel co-stimulatory molecules
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260855 Delivery of as-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
10/14/2010US20100260854 Granulate for the formulation of orodispersible tablets
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260807 Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
10/14/2010US20100260805 Peptide for vaccine
10/14/2010US20100260804 Attenuated Uracil Auxotroph of an Apicomplexan and Use Thereof
10/14/2010US20100260792 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
10/14/2010US20100260791 Chlamydia antigens
10/14/2010US20100260789 Products specific to pathogenic strains and their use as vaccines and in immunotherapy
10/14/2010US20100260788 Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties
10/14/2010US20100260781 Treatment methods for autoimmune disorders
10/14/2010US20100260776 Therapeutic method for reducing angiogenesis
10/14/2010US20100260773 Antibody molecules having binding specificity for human il-13
10/14/2010US20100260768 Anti mif antibodies
10/14/2010US20100260767 Composition and Method for Treating Inflammatory Disorders
10/14/2010US20100260761 Antibodies specifically reactive with a tumor necrosis factor related ligand
10/14/2010US20100260759 Immunosuppressive polypeptides and nucleic acids
10/14/2010US20100260755 Ibudilast and immunomodulators combination
10/14/2010US20100260742 Medicament and a method for regulation of the vascular tone
10/14/2010US20100260704 Human interferon-gamma (infgamma) variants
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/14/2010CA2758204A1 Immunogenic composition and uses thereof
10/14/2010CA2757933A1 Method for treating immune disorders
10/14/2010CA2757828A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010CA2757237A1 Anti-il-23 immunoglobulins
10/14/2010CA2755918A1 Oxadiazole derivatives
10/14/2010CA2754412A1 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjogren's syndrome
10/14/2010CA2753151A1 Substituted piperidines as ccr3 antagonists
10/13/2010EP2239269A1 Use of peptides derived from copolymer-1 as molecular weight markers
10/13/2010EP2239262A2 Fused ring heterocycle kinase modulators
10/13/2010EP2238253A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
10/13/2010EP2238144A1 Compounds comprising a cyclobutoxy group
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010CN1969986B Ganoderma lucidum capsule for improving sleep and immunity, preparation method and use thereof
10/13/2010CN1909925B Immunologic adjuvant
10/13/2010CN1891212B Oral preparation and its preparing method
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861317A Antihistaminic and antiallergic agent and a method for the production thereof
10/13/2010CN101857646A Method for extracting high-purity beta-glucan and whole oat flour from oat bran
10/13/2010CN101857636A Anti-interferon-alpha antibodies
10/13/2010CN101856494A Composition for improving immunity and preparation method thereof
10/13/2010CN101856427A Method for extracting solanine from potato peels
10/13/2010CN101856395A Method for preparing cistanche deserticola crude drug for decoction
10/13/2010CN101856387A Chinese herbal immunopotentiator for chicken
10/13/2010CN101856386A Manufacturing method of radix hedysari oral liquid
10/13/2010CN101856385A Composition containing echinacea extract and preparation method thereof
10/13/2010CN101856382A Novel method for extracting and separating platycodin effective ingredients
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 1172